Smith & Nephew plc (NYSE:SNN) Short Interest Update

Smith & Nephew plc (NYSE:SNN - Get Free Report) saw a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 3,120,000 shares, an increase of 28.4% from the October 31st total of 2,430,000 shares. Approximately 0.7% of the company's shares are short sold. Based on an average trading volume of 799,500 shares, the short-interest ratio is currently 3.9 days.

Wall Street Analyst Weigh In

SNN has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft cut shares of Smith & Nephew from a "buy" rating to a "hold" rating in a report on Friday, November 1st. Berenberg Bank cut shares of Smith & Nephew from a "buy" rating to a "hold" rating in a research report on Wednesday, November 6th. Finally, StockNews.com lowered shares of Smith & Nephew from a "strong-buy" rating to a "buy" rating in a report on Tuesday, November 12th.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Walleye Trading LLC bought a new position in shares of Smith & Nephew in the 1st quarter worth about $364,000. Boston Partners purchased a new stake in shares of Smith & Nephew in the 1st quarter worth approximately $2,524,000. Mather Group LLC. increased its position in Smith & Nephew by 9,735.3% during the 2nd quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider's stock valued at $42,000 after buying an additional 1,655 shares in the last quarter. Simplicity Wealth LLC raised its stake in Smith & Nephew by 13.4% during the second quarter. Simplicity Wealth LLC now owns 16,848 shares of the medical equipment provider's stock valued at $417,000 after buying an additional 1,993 shares during the last quarter. Finally, Opal Wealth Advisors LLC bought a new stake in Smith & Nephew in the second quarter worth $101,000. Institutional investors own 25.64% of the company's stock.

Smith & Nephew Trading Up 0.3 %

Smith & Nephew stock traded up $0.07 during mid-day trading on Friday, reaching $25.78. 250,520 shares of the company traded hands, compared to its average volume of 870,469. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11. Smith & Nephew has a 52-week low of $23.65 and a 52-week high of $31.72. The firm has a market capitalization of $11.27 billion, a price-to-earnings ratio of 13.09, a P/E/G ratio of 1.34 and a beta of 0.85. The firm's 50 day moving average price is $27.58 and its 200 day moving average price is $27.87.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.